DexCom's (DXCM) G6 CGM system and Omnipod 5 AID system can now simplify diabetes management and improve health outcomes in Germany.
DexCom stock (NASDAQ: DXCM) has seen a 17% fall in a month, compared to a 2% fall for the broader S&P500 index.

Is Trending Stock DexCom, Inc. (DXCM) a Buy Now?

10:31am, Wednesday, 30'th Aug 2023
Recently, Zacks.com users have been paying close attention to DexCom (DXCM). This makes it worthwhile to examine what the stock has in store.

Dexcom Announces Upcoming Conference Presentations

08:30am, Wednesday, 30'th Aug 2023
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming investor conferences: Jereme Sylvain, Executive V
CRISPR Therapeutics is using a novel technique to develop innovative therapies. Sarepta Therapeutics is developing medicines targeting a difficult-to-treat disease.
The latest jobs report showed a slowing pace of hiring which will affect stock market opportunities. The July jobs report showed slowing hiring with low unemployment.
Teladoc's solid position in telemedicine, improving bottom line, and strong margins make a solid case for the stock. Tandem Diabetes Care develops cutting-edge insulin pumps for diabetes patients, an
Wegovy and Mounjaro obesity and diabetes drugs are expected to have a significant impact on society and may lead to a decrease in demand for certain medical devices and surgeries. Medical device stock
Uncertainty from geopolitical tensions within the Ukraine war and China issues has led to slower United States labor market growth. In this environment of uncertainty, the United States labor market h
HCA Healthcare is a major player in an industry with no ceiling in sight. DexCom develops devices to help those with diabetes, a growing demographic.

5 Top Stocks Likely to Beat Earnings Estimates

08:11am, Wednesday, 02'nd Aug 2023
These top-ranked stocks are likely to beat on the bottom line in their upcoming releases. Tap Coty (COTY), BJ's Restaurants (BJRI), DexCom (DXCM), Livent (LTHM) and D.R.
Glucose-monitor maker DexCom Inc. NASDAQ: DXCM was among the top three gainers within the healthcare sector on July 28, advancing 2.33% in the season after gapping higher at the open.
Markets bounced back at midday on Friday, July 28, 2023 from yesterday's selloff and were heading for a winning week on the latest report showing inflation easing.
With a daily gain of 5.13%, DexCom Inc ( DXCM , Financial) has caught the attention of value investors. Its Earnings Per Share (EPS) (EPS) stands at 0.7.
DexCom's (DXCM) second-quarter 2023 results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Monitoring system.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE